Bio-Seal Lung Biopsy Tract Plug System Gets FDA Nod

The US Food and Drug Administration has approved the marketing of Canadian pharmaceutical company Angiotech’s device which seals lung punctures caused by biopsies.

The Bio-Seal Lung Biopsy Tract Plug System was approved for sale in the United States by the FDA with the health regulator stating that it will reduce the risk of collapsed lung among patients undergoing percutaneous transthoracic needle lung biopsy.

Lung Biopsy - Indications - Procedures - Risks - FAQs - Reference
The procedure by which tissue samples are obtained from the lung is known as lung biopsy. The biopsy tissues obtained from the lungs are examined by a pathologist.

The Bio-Seal system comes with a syringe that has been filled with a hydrogel which is solidified and dried. After the biopsy is conducted, doctors attach the system to the needle and inject the hydrogel through the stylet (a slender wire) into the empty space created by removing the lung tissue for the sample.

Angiotech CEO Thomas Bailey said that the device has shown to reduce the complications caused by lung biopsies. “Bio-Seal represents a significant and proprietary addition to our broad portfolio of products for the diagnosis of cancer. This device has been shown in clinical studies to significantly reduce complication rates in patients receiving a lung biopsy procedure, which we expect will enable physicians to more aggressively pursue diagnostic options for this patient population”, he said.

Lung Cancer - Types, Causes, Symptoms, Diagnosis, Treatment and Prevention
Lung cancer is a malignant tumor in the lung tissues. Smoking is the main cause of lung cancer with symptoms like recurrent respiratory diseases.

Source-Medindia

Congenital Cystic Adenomatoid Malformation Of The Lung
Congenital disease of the lung in which multiple cysts (water bubbles) develop in the lung tissues, sometimes affecting a whole lobe of the lungs.